Antileukemic effect of daclizumab in CD25 high-expressing leukemias and impact of tumor burden on antibody dosing - Concepedia

Concepedia

Publication | Closed Access

Antileukemic effect of daclizumab in CD25 high-expressing leukemias and impact of tumor burden on antibody dosing

37

Citations

21

References

2005

Year

Henry Koon, Peter Severy, David Hägg, Kathryn L. Butler, Thomas Hill, Alexander Jones, Thomas A. Waldmann, Richard P. Junghans

Leukemia Research

Hematological MalignancyCd25 High-expressing LeukemiasMedicineTumor BurdenImmunologyAntileukemic EffectImmune Checkpoint InhibitorCancer TreatmentImmunotherapyOncologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1

Page 1